Palatin Technologies
PTN
#9923
Rank
A$59.27 M
Marketcap
A$34.81
Share price
4.59%
Change (1 day)
2,314.53%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2025 (TTM): -A$26.32 Million

According to Palatin Technologies's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$40.78 Million, an increase over its 2023 earnings that were of -A$49.07 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$26.32 Million-35.46%
2024 -A$40.78 Million-16.9%
2023 -A$49.07 Million5.99%
2022 -A$46.3 Million-13.7%
2021 -A$53.65 Million33.25%
2020 -A$40.26 Million-172.11%
2019 A$55.82 M2352.33%
2018 A$2.27 M-94.13%
2017 A$38.79 M-154.92%
2016 -A$70.64 Million3.67%
2015 -A$68.14 Million878%
2014 -A$6.97 Million-72.64%
2013 -A$25.47 Million-33.11%
2012 -A$38.07 Million77.71%
2011 -A$21.42 Million
2003 -A$36.28 Million29.93%
2002 -A$27.92 Million36.18%
2001 -A$20.5 Million
1999 -A$17.02 Million6.04%
1998 -A$16.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
MediciNova
MNOV
-A$17.88 Million-31.72%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-A$44.64 Million 70.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$0.88 B-3,472.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
A$76.51 M-392.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$0.10 B-486.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-A$0.18 Billion 580.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$49.03 B-187,443.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-A$84.09 Million 221.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$19.81 B-75,798.43%๐Ÿ‡ฌ๐Ÿ‡ง UK